Wednesday, 11 December 2019 16:22

Creso Pharma launch medicinal cannabis product into Africa

By Creso Pharma

SPONSORED NEWS: Creso Pharma Limited (ASX:CPH) | FRA:1X8) has begun launch preparations of the cannaQIX® range into Africa.

Integrating into the African market is part of Creso’s drive to deliver its flagship medicinal cannabis product cannaQIX® 50 into new markets.

Working closely with leading South African pharmaceutical company, Pharma Dynamics, a subsidiary of Lupin Limited (NSE:LUPIN), Creso intends to launch cannaQIX® into the region in the March quarter of 2020.

Initial orders worth approximately A$300,000 for the cannaQIX® product range have been made.

The cannaQIX® range of products are cannabidiol (CBD) hemp oil-based nutraceuticals using Creso Pharma’s proprietary innovative delivery technology.

They contain broad spectrum hemp oil extract with CBD aiming to reduce stress and to support mental and nervous functions.

Pharma Dynamics is an important partner for Creso.

It has the sole distribution rights of Creso’s broad-spectrum hemp oil nutraceuticals cannaQIX® product range across South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Angola, Mozambique and Uganda.

Commenting on the collaboration with partner Pharma Dynamics and highlighting their ability to bring an affordable product to market in Africa, Creso Pharma’s chief executive and co-founder Miri Halperin Wernli said, “We are very excited to work together with our preferred partner Pharma Dynamics for the launch of the cannaQIX® product range into the first key countries in Africa.

‘’We are delighted to offer to the customer a top quality product with a top quality partner at an affordable price.”

Global expansion

CannaQIX®’s global market penetration has increased significantly in 2019. Its reach now extends to Canada, Latin America, Europe, Israel and the APAC region.

In August, Creso announced that it had entered an exclusive distribution agreement with JC Logistics Ltd trading as Medleaf Therapeutics for the exclusive distribution of cannaQIX® in New Zealand.

More recently, Creso announced the arrival of its first shipment of cannaQIX®50 in Australia, to be sold under the brand name ‘LozaCan’ through its exclusive Australian distributor, Burleigh Heads Cannabis.

Burleigh Heads Cannabis has confirmed prescriptions are already taking place and the product is receiving very positive feedback from physicians and patients.

cannaQIX® 50/LozaCan has been developed to Good Manufacturing Practice (GMP) standards and is produced in Switzerland by Creso Pharma’s partner, Switzerland-based food and pharma development company Domaco, Dr. med Aufdermaur AG to the highest Swiss quality with a ‘Swiss Made’ label.

Creso Pharma and Burleigh Heads Cannabis are exploring the potential to expand their collaboration to include additional therapeutic/medicinal cannabis products from Creso Pharma’s pipeline.

The delivery follows the recent signing of an exclusive Distribution Agreement with Burleigh Heads Cannabis in April, and the securing of an import permit for Australia.

The collaboration will enable Creso Pharma to leverage Burleigh Heads Cannabis and CDA’s local regulatory experience and established distribution networks to facilitate patient access to its products in Australia.

Burleigh Heads Cannabis is a subsidiary of CDA Health Pty Ltd, an established Australian business supporting patient access to medical cannabis products in Australia.

Discussing this milestone event and pointing to its significance in terms of new product launches, Dr Wernli said, “We are pleased to announce the first delivery of cannaQIX® 50 in Australia.

‘’Burleigh Heads Cannabis and CDA Clinics Australia continue to rapidly expand their patient reach with their extensive distribution network.

“This close partnership enables us to fulfil our mission of bringing life-improving products to patients in Australia.

2020 outlook

Developments in Australia along with the new sales being generated in Africa will assist Creso in delivering strong revenue growth in fiscal 2020.

Its portfolio of cannabis and hemp-derived products focuses on the four key areas of therapeutics nutraceuticals, animal health, and cosmetics.

The company currently has a portfolio of 13 products which have been developed with pharmaceutical expertise and methodological rigour by a qualified pharmaceutical team. Four products have been commercialised, and are generating sales, and nine are pending commercialisation.

Creso anticipates signing with more commercial partners to expand the commercial reach of its two existing human health products cannaQIX® 10 and cannaQIX® 50 and to introduce the newly developed products in additional European countries.

The company is prioritising Spain, Portugal, the Scandinavian countries, as well as Poland and Israel.

As for its animal health products, partner Virbac is introducing the two initial anibidiol® products into further countries in Europe and will be launching Creso Pharma’s new animal health products in the near future.


Subscribe to ITWIRE UPDATE Newsletter here

GRAND OPENING OF THE ITWIRE SHOP

The much awaited iTWire Shop is now open to our readers.

Visit the iTWire Shop, a leading destination for stylish accessories, gear & gadgets, lifestyle products and everyday portable office essentials, drones, zoom lenses for smartphones, software and online training.

PLUS Big Brands include: Apple, Lenovo, LG, Samsung, Sennheiser and many more.

Products available for any country.

We hope you enjoy and find value in the much anticipated iTWire Shop.

ENTER THE SHOP NOW!

INTRODUCING ITWIRE TV

iTWire TV offers a unique value to the Tech Sector by providing a range of video interviews, news, views and reviews, and also provides the opportunity for vendors to promote your company and your marketing messages.

We work with you to develop the message and conduct the interview or product review in a safe and collaborative way. Unlike other Tech YouTube channels, we create a story around your message and post that on the homepage of ITWire, linking to your message.

In addition, your interview post message can be displayed in up to 7 different post displays on our the iTWire.com site to drive traffic and readers to your video content and downloads. This can be a significant Lead Generation opportunity for your business.

We also provide 3 videos in one recording/sitting if you require so that you have a series of videos to promote to your customers. Your sales team can add your emails to sales collateral and to the footer of their sales and marketing emails.

See the latest in Tech News, Views, Interviews, Reviews, Product Promos and Events. Plus funny videos from our readers and customers.

SEE WHAT'S ON ITWIRE TV NOW!

BACK TO HOME PAGE
Share News tips for the iTWire Journalists? Your tip will be anonymous

WEBINARS ONLINE & ON-DEMAND

GUEST ARTICLES

VENDOR NEWS

Guest Opinion

Guest Reviews

Guest Research

Guest Research & Case Studies

Channel News

Comments